Opening Panel Discussion: Understanding the Benefits and Pitfalls of Artificial Intelligence in Oncology

Friday, November 15, 2024

8:30 AM – 9:45 AM CT

Location: Grapevine Ballroom

CE: 1.25 credits/hours

Moderator(s)

Erin Fidyk, ANP-BC, MBA (she/her/hers)

Senior Clinical Director
Flatiron Health
Boston, Massachusetts, United States

Panelist(s)

Leslie Gutierrez, AGACNP-BC, APRN, MSN (she/her/hers)

Acute Care Nurse Practitioner - Medical Oncology/Hematology
Texas Oncology
Rosenberg, Texas, United States
Rachele Hendricks-Sturrup, DHSc, MSc, MA

Research Director of Real-World Evidence
Duke-Margolis Institute for Health Policy
Washington, District of Columbia, United States
Erica Olenski (she/her/hers)

Founding Executive Director
August's Artists
Mckinney, Texas, United States
Erika Ramsdale, MD, MS (she/her/hers)

Associate Professor of Medicine, Director of Informatics
Wilmot Cancer Institute, University of Rochester Medical Center
Pittsford, New York, United States

Disclosures:

Erin Fidyk is an employee of Flatiron Health and holds Roche stock.
Leslie Gutierrez, Rachele Hendricks-Sturrup, Erica Olenski, and Erika Ramsdale have no relevant financial relationships to disclose.

Learning Objectives:

Define artificial intelligence (AI) as technology that enables computers to simulate intelligent behavior
Examine the potential benefits of AI integration into oncology practice to help improve clinical outcomes
Explore practical strategies for integrating AI into clinical practice, including in screening, diagnosis, management, and survivorship
Discuss how patients and caregivers are using AI tools to advocate for themselves in care delivery and legislation
Explain how patients and caregivers are using AI tools to navigate trauma and relieve patient and caregiver administrative burden